HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$2.93
Day range
$2.96 - $3.09
Year range
$1.19 - $4.32
Market cap
523.49M USD
Avg Volume
5.88M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.79M | -62.33% |
Operating expense | 22.85M | 12.11% |
Net income | -25.52M | 78.20% |
Net profit margin | -1.43K | 42.14% |
Earnings per share | -0.07 | 92.32% |
EBITDA | -20.77M | -35.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.69M | -4.01% |
Total assets | 180.22M | -7.94% |
Total liabilities | 91.42M | -62.67% |
Total equity | 88.80M | — |
Shares outstanding | 204.94M | — |
Price to book | 6.81 | — |
Return on assets | -27.67% | — |
Return on capital | -33.01% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -25.52M | 78.20% |
Cash from operations | -21.62M | -20.42% |
Cash from investing | -35.00K | 99.00% |
Cash from financing | 6.60M | -95.31% |
Net change in cash | -15.06M | -112.63% |
Free cash flow | -12.60M | -110.54% |
About
Founded
2019
Headquarters
Website
Employees
52
